Company Profile

Generation Biotech LLC
Profile last edited on: 6/7/2018      CAGE: 470E7      UEI:

Business Identifier: Tools for complex DNA analysis.: Haplotyping Technology
Year Founded
2001
First Award
2003
Latest Award
2019
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1 Craven Lane Unit 6174
Lawrenceville, NJ 08648
   (609) 637-0878
   info@generationbiotech.com
   www.gen-bio.com
Location: Multiple
Congr. District: 03
County: Mercer

Public Profile

Generation Biotech provides tools for complex DNA analysis. Employing a methodology first used at Princeton University, to simplify the process while also making it more reliable, Experience in single molecule analysis and single nucleotide polymorphism (SNP) typing led to the development of a molecular enrichment and haplotyping method for separating the maternal and paternal copies from a patientÂ’s genomic DNA sample using magnetic particles. Originally ganized around adressing the issues of tissue-typing for organ donation, the rocess was commercialized in collaboration with GenoVision, Inc. The resulting HaploPrep product resolves all genotyping ambiguities found in the Human Leukocyte Antigen (HLA) gene region. Generation Biotech continues to develop new technologies for the separation of genomic DNA, DNA-associated proteins and specific cells. Region Specific Extraction (RSE) captures specific genomic regions of interest and is used for mapping copy number and location of viral insertions and transposable genetic elements. These technologies advance the efforts of disease association studies, whole genome re-sequencing efforts, QTL mapping and plant breeding. Experience in single molecule analysis and single nucleotide polymorphism (SNP) typing led to the development of a molecular enrichment and haplotyping method for separating the maternal and paternal copies from a patientÂ’s genomic DNA sample using magnetic particles.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Johannes Dapprich -- President

Company News

There are no news available.